July 02, 2021 Smaller companies set for third-quarter catalysts The third quarter will see important data for Travere, Radius and Sio Gene, among other small developers.
March 25, 2020 Astrazeneca throws Silence an $80m lifeline Silence has received an important validation, but making progress could be tough.
